相似文献
1
Monoclonal antibodies to lipoarabinomannan/arabinomannan - characteristics and implications for tuberculosis research and diagnostics.
Trends Microbiol. 2023 Jan;31(1):22-35. doi: 10.1016/j.tim.2022.07.001. Epub 2022 Jul 30.
2
Generation of mycobacterial lipoarabinomannan-specific monoclonal antibodies and their ability to identify mycobacterium isolates.
J Microbiol Immunol Infect. 2021 Jun;54(3):437-446. doi: 10.1016/j.jmii.2020.02.005. Epub 2020 Feb 20.
3
Monoclonal antibodies from humans with Mycobacterium tuberculosis exposure or latent infection recognize distinct arabinomannan epitopes.
Commun Biol. 2021 Oct 12;4(1):1181. doi: 10.1038/s42003-021-02714-w.
4
A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.
J Clin Microbiol. 2018 Nov 27;56(12). doi: 10.1128/JCM.01338-18. Print 2018 Dec.
5
Tailor made: New insights into lipoarabinomannan structure may improve TB diagnosis.
J Biol Chem. 2022 Mar;298(3):101678. doi: 10.1016/j.jbc.2022.101678. Epub 2022 Feb 2.
6
A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.
Clin Exp Immunol. 2004 Oct;138(1):30-8. doi: 10.1111/j.1365-2249.2004.02593.x.
7
Impact of Methylthioxylose Substituents on the Biological Activities of Lipomannan and Lipoarabinomannan in .
ACS Infect Dis. 2024 Apr 12;10(4):1379-1390. doi: 10.1021/acsinfecdis.4c00079. Epub 2024 Mar 21.
8
Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan.
JCI Insight. 2023 Oct 23;8(20):e167960. doi: 10.1172/jci.insight.167960.
9
Development of an Orthogonal Protection Strategy for the Synthesis of Mycobacterial Arabinomannan Fragments.
J Org Chem. 2015 Nov 20;80(22):11417-34. doi: 10.1021/acs.joc.5b02083. Epub 2015 Nov 10.
10
Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
PLoS Med. 2019 Apr 12;16(4):e1002780. doi: 10.1371/journal.pmed.1002780. eCollection 2019 Apr.
引用本文的文献
1
Strategies for shortening tuberculosis therapy.
Nat Med. 2025 Jun;31(6):1765-1775. doi: 10.1038/s41591-025-03742-3. Epub 2025 Jun 13.
2
Real-world diagnostic accuracy of lipoarabinomannan in three non-sputum biospecimens for pulmonary tuberculosis disease.
EBioMedicine. 2024 Oct;108:105353. doi: 10.1016/j.ebiom.2024.105353. Epub 2024 Sep 26.
3
Selective Glycan Labeling of Mannose-Containing Glycolipids in Mycobacteria.
J Am Chem Soc. 2024 Jan 10;146(1):377-385. doi: 10.1021/jacs.3c09495. Epub 2023 Dec 19.
4
Blazing the trail for innovative tuberculosis diagnostics.
Infection. 2024 Feb;52(1):29-42. doi: 10.1007/s15010-023-02135-3. Epub 2023 Nov 30.
5
Collected Thoughts on Mycobacterial Lipoarabinomannan, a Cell Envelope Lipoglycan.
Pathogens. 2023 Oct 26;12(11):1281. doi: 10.3390/pathogens12111281.
6
Immunoassay with Novel Paired Antibodies for Detection of Lipoarabinomannan in the Pleural Fluid and Plasma of Patients with Tuberculous Pleurisy.
Microorganisms. 2023 Sep 8;11(9):2259. doi: 10.3390/microorganisms11092259.
7
Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan.
JCI Insight. 2023 Oct 23;8(20):e167960. doi: 10.1172/jci.insight.167960.
8
Impact of Mycobacterium tuberculosis Glycolipids on the CD4+ T Cell-Macrophage Immunological Synapse.
J Immunol. 2023 Nov 1;211(9):1385-1396. doi: 10.4049/jimmunol.2300107.
9
Antibodies Targeting the Cell Wall Induce Protection against Virulent Mycobacterium bovis Infection.
Microbiol Spectr. 2023 Feb 27;11(2):e0343122. doi: 10.1128/spectrum.03431-22.
10
A Mycobacterium tuberculosis fingerprint in human breath allows tuberculosis detection.
Nat Commun. 2022 Dec 14;13(1):7751. doi: 10.1038/s41467-022-35453-5.
本文引用的文献
1
Tailor made: New insights into lipoarabinomannan structure may improve TB diagnosis.
J Biol Chem. 2022 Mar;298(3):101678. doi: 10.1016/j.jbc.2022.101678. Epub 2022 Feb 2.
2
Robust IgM responses following intravenous vaccination with Bacille Calmette-Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques.
Nat Immunol. 2021 Dec;22(12):1515-1523. doi: 10.1038/s41590-021-01066-1. Epub 2021 Nov 22.
3
Monoclonal antibodies from humans with Mycobacterium tuberculosis exposure or latent infection recognize distinct arabinomannan epitopes.
Commun Biol. 2021 Oct 12;4(1):1181. doi: 10.1038/s42003-021-02714-w.
4
Structural implications of lipoarabinomannan glycans from global clinical isolates in diagnosis of Mycobacterium tuberculosis infection.
J Biol Chem. 2021 Nov;297(5):101265. doi: 10.1016/j.jbc.2021.101265. Epub 2021 Sep 30.
5
Immobilization of Proteinase K for urine pretreatment to improve diagnostic accuracy of active tuberculosis.
PLoS One. 2021 Sep 21;16(9):e0257615. doi: 10.1371/journal.pone.0257615. eCollection 2021.
6
Secondary Extended Mannan Side Chains and Attachment of the Arabinan in Mycobacterial Lipoarabinomannan.
Commun Chem. 2020;3(1). doi: 10.1038/s42004-020-00356-3. Epub 2020 Aug 7.
7
Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It?
Front Microbiol. 2021 Apr 15;12:638047. doi: 10.3389/fmicb.2021.638047. eCollection 2021.
8
B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis.
Front Immunol. 2021 Feb 18;12:640168. doi: 10.3389/fimmu.2021.640168. eCollection 2021.
9
Urine lipoarabinomannan in HIV uninfected, smear negative, symptomatic TB patients: effective sample pretreatment for a sensitive immunoassay and mass spectrometry.
Sci Rep. 2021 Feb 3;11(1):2922. doi: 10.1038/s41598-021-82445-4.
10
The knowns and unknowns of latent Mycobacterium tuberculosis infection.
J Clin Invest. 2021 Feb 1;131(3). doi: 10.1172/JCI136222.
Zotero 插件